Award notice, first published as sources sought
Notice of Intent to Sole Source Biofire Global Fever Test Kits at U.S. Naval Hospital Okinawa, Japan
HT941024N0092
Defense Health Agency (Dha), Defense Health Agency HCD West. In-Vitro Diagnostic Substance Manufacturing.
Awarded
$38,820.00 on the award notice, July 11, 2024, contract HT941024P0187
Get the next one like this from Defense Health Agency (Dha) by email, the day it is posted.Find my opportunities
This one was awarded in 2024
13 like it are open now in in-vitro diagnostic substance manufacturing
- NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes tomorrowNov 2 - HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325413Anywhere in the US36C26227Q0046Closes tomorrowNov 2 - DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325413Anywhere in the US36C77027Q0015Closes in 2 daysNov 3
Description
As published on SAM.gov.
The Defense Health Agency, Contracting Office - San Diego (HT9410), 7700 Arlington Blvd., Falls Church, VA 22042, has awarded a firm-fixed price (FFP), supply contract. The supplies provide BioFire Global Fever Special Pathogens Panel IVD, 6 Test (27 PG), and BioFire Shield Control Kit for GFSPP, 12 controls (2 PG). at U.S. Naval Hospital Okinawa, Japan. This sole source and firm-fixed price contract was awarded to Biofire Defense LLC on 11 July 202 for a one-time purchase base and no option pedriods.
Total contract value is $38,820.00. Biofire Defense LLC is the Original Equipment Manufacturer (OEM) of the BioFire Global Fever Special Pathogens Panel and BioFire Shield Control Kits. BioMérieux is the parent company.
However, BioFire Defense was created specifically to retain confidentiality of U.S. Government strategic assets under the Foreign Ownership Control and Influence (FOCI) mitigation agreement between the US Government, BioFire Defense (BFDF), BioMérieux, and all Affiliate companies owned by BioMérieux.
Because of this and its corresponding MOU, all US Department of Defense accounts fall solely under BioFire Defense LLC. Additionally, BioMérieux does not have authorization to sell the Global Fever Special Pathogens Test kits or Global Fever Special Pathogens SHIELD control kits. These kits are only available to be ordered through BioFire Defense. The second part of the Sole Source letter specifies that BioFire is the sole provider, and not BioMérieux.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Biofire Defense LLC
- UEI
- NHMDGM122546
- CAGE
- 088J2
- Vendor location
- Salt Lake City, UT
- Contract
- HT941024P0187, purchase order
- Obligated
- $38,820.00
- Actions
- 1 between July 11, 2024 and July 11, 2024
- Competition
- Not Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Biofire Global Fever Special Pathogens Tests
- Match
- award number HT941024P0187 equals the contract number; same awarding office HT9410 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Adrian Neridaadrian.m.nerida.civ@health.mil6197231493
- Pedro Reyespedro.a.reyes10.civ@health.mil2107925689